Lanthanum carbonate for the control of hyperphosphatemia in chronic renal failure patients: a new oral powder formulation – safety, efficacy, and patient adherence

Chronic kidney disease (CKD) is associated with very high mortality rates, mainly of cardiovascular origin. The retention of phosphate (P) and increased fibroblast growth factor-23 levels are common, even at early stages of CKD, due to disturbances in normal P homeostasis. Later, hyperphosphatemia a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lloret, MªJesús, Ruiz-García, César, DaSilva, Iara, Furlano, Mónica, Barreiro, Yaima, Ballarín, José, Bover, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826937/
https://www.ncbi.nlm.nih.gov/pubmed/24235818
http://dx.doi.org/10.2147/PPA.S31694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826937/
https://www.ncbi.nlm.nih.gov/pubmed/24235818
http://dx.doi.org/10.2147/PPA.S31694

Ejemplares similares